Skip to main content

MoneyWorks4Me

Parmax Pharma informs about details of loss of certificate

17 Jun 2023 Evaluate
Parmax Pharma has informed about intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a Letter of Confirmation will be issued to the securities holder/claimant upon completion of necessary procedures regarding duplicate Share Certificate.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..